Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, Geospiza Integrate Software for Next-Gen Sequencing Data

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ingenuity Systems today said it and Geospiza will integrate their software products in a collaboration that will allow researchers to gain "deep biological insights from their project samples."

Under the deal, Ingenuity will integrate its IPA software with Geospiza's GeneSifter to create a "rapid and reliable" workflow for the analysis and visualization of next-generation sequencing data, the Redwood City, Calif.-based company said.

Terms of the deal were not disclosed.

In a statement, Todd Smith, Chief Technology Officer for Geospiza said, "Our integration with IPA will accelerate drug discovery and 'omics research pipelines by enabling NGS researchers to understand and visualize their data in the context of known biological processes, functions, diseases, pathways and relationships, through IPA's powerful analysis capabilities and the timely, detailed information in the Ingenuity Knowledge Base."

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.